BIOMAT Database Logo BIOMAT Database Logo

Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein. 2014

Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Institute of Medical Chemistry, Medical University Vienna, Waehringer Strasse 10, 1090 Vienna, Austria; Abdul Wali Khan University Mardan, Malakand Mardan Rd, Mardan, Pakistan.

P-glycoprotein (P-gp) is an ATP-dependent multidrug resistance efflux transporter that plays an important role in anticancer drug resistance and in pharmacokinetics of medicines. Despite a large number of structurally and functionally diverse compounds, also flavonoids and chalcones have been reported as inhibitors of P-gp. The latter share some similarity with the well studied class of propafenones, but do not contain a basic nitrogen atom. Furthermore, due to their rigidity, they are suitable candidates for 3D-QSAR studies. In this study, a set of 22 new chalcone derivatives were synthesized and evaluated in a daunomycin efflux inhibition assay using the CCRF.CEM.VCR1000 cell line. The compound 10 showed the highest activity (IC50=42nM), which is one order of magnitude higher than the activity for an equilipohillic propafenone analogue. 2D- and 3D-QSAR studies indicate the importance of H-bond acceptors, methoxy groups, hydrophobic groups as well as the number of rotatable bonds as pharmacophoric features influencing P-gp inhibitory activity.

UI MeSH Term Description Entries
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D020168 ATP Binding Cassette Transporter, Subfamily B, Member 1 A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE). ATP-Dependent Translocase ABCB1,MDR1 Protein,MDR1B Protein,Multidrug Resistance Protein 1,P-Glycoprotein,P-Glycoprotein 1,ABCB1 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 1,ATP-Binding Cassette, Sub-Family B, Member 1,CD243 Antigen,PGY-1 Protein,1, P-Glycoprotein,ABCB1, ATP-Dependent Translocase,ATP Dependent Translocase ABCB1,Antigen, CD243,P Glycoprotein,P Glycoprotein 1,PGY 1 Protein,Protein, MDR1B,Translocase ABCB1, ATP-Dependent
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
February 2013, Bioorganic & medicinal chemistry letters,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
April 2012, Bioorganic & medicinal chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
September 2020, European journal of medicinal chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives.
March 2007, Bioorganic & medicinal chemistry letters,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors.
June 2012, Bioorganic & medicinal chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
July 2010, Bioorganic & medicinal chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
October 2015, European journal of medicinal chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Synthesis, antihypertensive activity, and 3D-QSAR studies of some new p-hydroxybenzohydrazide derivatives.
February 2011, Archiv der Pharmazie,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors.
June 2017, Bioorganic chemistry,
Zahida Parveen, and Gerda Brunhofer, and Ishrat Jabeen, and Thomas Erker, and Peter Chiba, and Gerhard F Ecker
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation.
March 2013, Journal of medicinal chemistry,
Copied contents to your clipboard!